Leonard Sank - 08 Aug 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Leonard Sank
Issuer symbol
ORMP
Transactions as of
08 Aug 2022
Net transactions value
+$3.92
Form type
4
Filing time
10 Aug 2022, 16:30:51 UTC
Previous filing
01 Aug 2022
Next filing
20 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Options Exercise $81,600 +20,000 +111% $4.08 38,000 08 Aug 2022 Direct
transaction ORMP Common Stock Tax liability $81,596 -9,304 -24% $8.77 28,696 08 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option Options Exercise $0 -20,000 -100% $0.000000* 0 08 Aug 2022 Common Stock 20,000 $4.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price.
F2 The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014.